As of 4:00pm ET
| -0.29 / -1.65%|
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
|Kåre Schultz||President, Chief Executive Officer & Director|
|Carlo de Notaristefani||Executive Vice President-Global Operations|
|Michael McClellan||Chief Financial Officer & Executive Vice President|
|David Stark||Chief Legal Officer & Executive Vice President|
|Nir Baron||Chief Internal Auditor & Executive Vice President|